According to Market Research Future®, the Medical Injection Molding Market was valued at USD 19.1 billion in 2024 and is projected to reach USD 20.15 billion in 2025 before expanding to USD 34.32 billion by 2035, registering a CAGR of 5.47% during the forecast period. Market growth is supported by rising demand for medical devices, technological advancements, sustainability initiatives, personalized medicine, innovations in material science, and the growth of the aging population. Major companies operating in the market include Medtronic, Johnson & Johnson, Becton Dickinson, Thermo Fisher Scientific, Stryker, and Boston Scientific.

Market Overview

Medical injection molding is an important manufacturing process for producing precise, scalable, and cost-efficient medical components and devices. The technology is used for single-use and reusable medical devices, supporting applications such as surgical instruments, medical implants, diagnostic devices, and drug delivery devices.

The market uses thermoplastics, thermosets, and bioplastics. These materials offer manufacturers flexibility in designing products with specific requirements for durability, sterilization, biocompatibility, and performance.

Market Size Reached in 2025

The market is projected to reach USD 20.15 billion in 2025. Increasing healthcare expenditure and the rising need for advanced medical equipment are supporting demand for injection-molded components.

Medical device manufacturers represent a major end-use group, while hospitals, clinics, and pharmaceutical companies also contribute to market demand.

Expected Market Size by 2035

The market is expected to reach USD 34.32 billion by 2035. Growth is expected to be supported by the increasing production of medical devices, expanding healthcare infrastructure, and continued development of specialized medical technologies.

The aging population is also expected to increase demand for healthcare products and devices, creating additional opportunities for manufacturers.

Market CAGR

The market is forecast to expand at a CAGR of 5.47% from 2025 to 2035. This growth reflects the steady expansion of medical device manufacturing and the increasing adoption of advanced production methods.

Key Growth Drivers

Rising demand for medical devices is a major market driver. Hospitals, clinics, and healthcare providers require increasingly sophisticated equipment and disposable products.

Technological advancements are improving manufacturing precision, automation, and production efficiency.

Personalized medicine is also creating demand for specialized devices and components designed for specific clinical applications.

Emerging Market Trends

Sustainability is influencing the development of materials and manufacturing processes.

Innovations in material science are expanding the use of thermoplastics, bioplastics, and other advanced materials.

The integration of automation and advanced production technologies is also improving quality and efficiency.

Competitive Landscape

The competitive landscape is shaped by manufacturing expertise, product innovation, material technology, regulatory capabilities, and global distribution networks.

Medtronic, Johnson & Johnson, Becton Dickinson, Thermo Fisher Scientific, Stryker, and Boston Scientific are among the major companies operating in the market.